US 12201719
Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy
granted A61KA61K2035/122A61K2039/505
Quick answer
US patent 12201719 (Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy) held by VACCINEX, INC. expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VACCINEX, INC.
- Grant date
- Tue Jan 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2035/122, A61K2039/505, A61K2239/31, A61K2239/49